Anyone have any guesses if there are any trials underway for Leronlimab other than COVID-19? If so, would any of those trial patients ever show even mild COVID-19 symptoms if already being treated with Leronlimab?
Second question would be if a COVID-19 trials patient gets treated with Leronlimab and in the course of their COVID-19 treatment doctors discover they have one of the types of Leronlimab potentially treatable cancers, do they....
1) Once patient recovers from COVID-19 send them on to oncology for "traditional" treatment?
2) Once patient recovers from COVID-19 send them directly into the trials for the cancer they are being treated for?
3) Keep patient on Leronlimab and move them directly to EIND for their cancer?